Salt: Olaparib (150mg)
Prescription Required: Yes
See Similar Products
Ibyra 150mg Tablet
MRP: ₹14995.00 Discount: 37%
Sale Price:
Sale Price:
₹9500.00
Ibyra 150mg Tablet is a prescription medicine used in the treatment of ovarian and breast cancer. It works by blocking an enzyme called PARP, which helps fix damaged DNA. By stopping PARP, the medicine prevents cancer cells from repairing themselves, leading them to die off and slowing tumor growth.
Weight/Quantity: 60 Tablets in 1 Bottle
Store at 25°C temperature.
Ibyra 150mg Tablet belongs to the class of cancer medications known as PARP (poly [adenosine diphosphate-ribose] polymerase inhibitor) inhibitors, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. This medication can be given alone or in combination with other anticancer medications.
Benefits of Ibyra Tablet
1.In Treatment of Ovarian cancer
Ibyra 150mg Tablet helps prevent the cancer from worsening for a longer period. The medicine is effective in both newly diagnosed cases and in recurrent ovarian cancer, offering a maintenance therapy option that can delay the need for further chemotherapy. This targeted therapy can lead to better management of the disease with a more personalized approach, improving overall outcomes and quality of life for patients.
2.In Treatment of Breast cancer
Ibyra 150mg Tablet provides a targeted treatment option that specifically attacks cancer cells while sparing most healthy cells. Clinical studies have shown that Ibyra 150mg Tablet can significantly reduce the risk of cancer progression or recurrence and improve survival rates. By specifically inhibiting the PARP enzyme in cancer cells, Ibyra 150mg Tablet helps to slow the spread of the disease, providing patients with a more effective and less toxic treatment option.
1.In Treatment of Ovarian cancer
Ibyra 150mg Tablet helps prevent the cancer from worsening for a longer period. The medicine is effective in both newly diagnosed cases and in recurrent ovarian cancer, offering a maintenance therapy option that can delay the need for further chemotherapy. This targeted therapy can lead to better management of the disease with a more personalized approach, improving overall outcomes and quality of life for patients.
2.In Treatment of Breast cancer
Ibyra 150mg Tablet provides a targeted treatment option that specifically attacks cancer cells while sparing most healthy cells. Clinical studies have shown that Ibyra 150mg Tablet can significantly reduce the risk of cancer progression or recurrence and improve survival rates. By specifically inhibiting the PARP enzyme in cancer cells, Ibyra 150mg Tablet helps to slow the spread of the disease, providing patients with a more effective and less toxic treatment option.
Take this medicine in the dose and duration as advised by your doctor.
Take this medicine in the dose and duration as advised by your doctor.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Ibyra
Nausea
Vomiting
Fatigue
Diarrhea
Loss of appetite
Headache
Anemia (low number of red blood cells)
Decreased blood cells (red cells, white cells, and platelets)
Taste change
Cough
Breathlessness
Indigestion
Abdominal pain
Common side effects of Ibyra
Nausea
Vomiting
Fatigue
Diarrhea
Loss of appetite
Headache
Anemia (low number of red blood cells)
Decreased blood cells (red cells, white cells, and platelets)
Taste change
Cough
Breathlessness
Indigestion
Abdominal pain
